Simon Raymond*

Professor, Alumnus, Melbourne University, Australia

*Corresponding Author: Simon Raymond, Professor, Alumnus, Melbourne University, Australia.

Received: April 29, 2021; Published: May 07, 2021

Citation: Simon Raymond. “Site Attachment Inhibition: Research Note”. Acta Scientific Microbiology 4.6 (2021): 25.

Keywords: Spermatogenesis; Oogenesis; Stem Cell Therapy

One issue with stem cell therapy immunization is that it requires the embryo to undergo stem cell therapy and not all pregnancies are identified this early.

  The solution to this has already been discussed. Stem cell therapy could be carried out at spermatogenesis and oogenesis. The genes targeted that which correspond to embryonic CCR5-Δ32, taking into account association versus causation.

Whilst this may seem burdensome, it depends how keen society is to eradicate HIV.

Ethics approval has been granted for embryonic stem cell therapy above but not yet for oogenesis and spermatogenesis.

Conclusion

One issue with stem cell therapy immunization is that it requires the embryo to undergo stem cell therapy and not all pregnancies are identified this early.

The solution to this has already been discussed. Stem cell therapy could be carried out at spermatogenesis and oogenesis.

Copyright: © 2021 Simon Raymond. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.